Unity Biotechnology Inc Reports Results For The Quarter Ended In December: Earnings Summary

Unity Biotechnology

15/03/2023 21:06

* UNITY Biotechnology Inc  UBX.OQ  reported a quarterly
adjusted
loss of 100 cents​​ per share for the quarter ended in December.
The mean expectation of four analysts for the quarter was for a
loss of $1.05 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * UNITY Biotechnology Inc's reported EPS for the quarter was
a
loss of $1.00​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * UNITY Biotechnology Inc shares had risen by 52.2% this
quarter.
    * The company reported a quarterly loss of $14.17 million.
    * Wall Street's median 12-month price target for UNITY
Biotechnology Inc is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 15 at 09:05 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -1.05          -1.00          Beat
 Sep. 30 2022      -1.65          -1.36          Beat
 Jun. 30 2022      -2.80          -1.90          Beat
 Mar. 31 2022      -2.57          -2.80          Missed